Plasma morphine and morphine-6-glucuronide during chronic morphine therapy for cancer pain: plasma profiles, steady-state concentrations and the consequences of renal failure (Q67823700)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 October 1991

Language	Label	Description	Also known as
English	Plasma morphine and morphine-6-glucuronide during chronic morphine therapy for cancer pain: plasma profiles, steady-state concentrations and the consequences of renal failure	scientific article published on 01 October 1991

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1771088%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

Plasma morphine and morphine-6-glucuronide during chronic morphine therapy for cancer pain: plasma profiles, steady-state concentrations and the consequences of renal failure (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1771088%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Anesthesiology and pain medicine

1 reference

10.1016/0304-3959(91)90005-I

https://api.crossref.org/works/10.1016/0304-3959(91)90005-I

19 November 2022

1 reference

10.1016/0304-3959(91)90005-I

https://api.crossref.org/works/10.1016/0304-3959(91)90005-I

19 November 2022

author name string

Russell K. Portenoy

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1771088

19 November 2022

Kathleen M. Foley

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1771088

19 November 2022

James Stulman

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1771088

19 November 2022

Elizabeth Khan

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1771088

19 November 2022

Jean Adelhardt

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1771088

19 November 2022

Mary Layman

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1771088

19 November 2022

Daniel F. Cerbone

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1771088

19 November 2022

Charles E. Inturrisi

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1771088

19 November 2022

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1771088

19 November 2022

publication date

1 October 1991

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1771088%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

full work available at URL

https://journals.lww.com/10.1016/0304-3959(91)90005-I

1 reference

10.1016/0304-3959(91)90005-I

https://api.crossref.org/works/10.1016/0304-3959(91)90005-I

19 November 2022

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1771088%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

47

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1771088%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1771088%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

13-19

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1771088%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

Morphine-6-glucuronide: analgesic effects and receptor binding profile in rats.

1

1 reference

10.1016/0304-3959(91)90005-I

https://api.crossref.org/works/10.1016/0304-3959(91)90005-I

19 November 2022

Persistently increased morphine-6-glucuronide concentrations

2

1 reference

10.1016/0304-3959(91)90005-I

https://api.crossref.org/works/10.1016/0304-3959(91)90005-I

19 November 2022

Chronic nausea and morphine-6-glucuronide

3

1 reference

10.1016/0304-3959(91)90005-I

https://api.crossref.org/works/10.1016/0304-3959(91)90005-I

19 November 2022

Potential analgesic contribution from morphine-6-glucuronide in CSF

4

1 reference

10.1016/0304-3959(91)90005-I

https://api.crossref.org/works/10.1016/0304-3959(91)90005-I

19 November 2022

Analgesic efficacy and CSF pharmacokinetics of intrathecal morphine-6-glucuronide: comparison with morphine

5

1 reference

10.1016/0304-3959(91)90005-I

https://api.crossref.org/works/10.1016/0304-3959(91)90005-I

19 November 2022

Central nervous system excitatory effects of meperidine in cancer patients

8

1 reference

10.1016/0304-3959(91)90005-I

https://api.crossref.org/works/10.1016/0304-3959(91)90005-I

19 November 2022

Potency of oral morphine

9

1 reference

10.1016/0304-3959(91)90005-I

https://api.crossref.org/works/10.1016/0304-3959(91)90005-I

19 November 2022

Morphine intoxication in renal failure: the role of morphine-6-glucuronide

11

1 reference

10.1016/0304-3959(91)90005-I

https://api.crossref.org/works/10.1016/0304-3959(91)90005-I

19 November 2022

Analgesic activity of morphine-6-glucuronide

12

1 reference

10.1016/0304-3959(91)90005-I

https://api.crossref.org/works/10.1016/0304-3959(91)90005-I

19 November 2022

Morphine and metabolite behavior after different routes of morphine administration: demonstration of the importance of the active metabolite morphine-6-glucuronide

13

1 reference

10.1016/0304-3959(91)90005-I

https://api.crossref.org/works/10.1016/0304-3959(91)90005-I

19 November 2022

Morphine-6-glucuronide, a potent mu agonist.

14

1 reference

10.1016/0304-3959(91)90005-I

https://api.crossref.org/works/10.1016/0304-3959(91)90005-I

19 November 2022

Plasma levels of morphine and morphine glucuronides in the treatment of cancer pain: relationship to renal function and route of administration

16

1 reference

10.1016/0304-3959(91)90005-I

https://api.crossref.org/works/10.1016/0304-3959(91)90005-I

19 November 2022

Relative bioavailability of controlled release morphine tablets (MST continus) in cancer patients

17

1 reference

10.1016/0304-3959(91)90005-I

https://api.crossref.org/works/10.1016/0304-3959(91)90005-I

19 November 2022

High-dose morphine and methadone in cancer patients. Clinical pharmacokinetic considerations of oral treatment

18

1 reference

10.1016/0304-3959(91)90005-I

https://api.crossref.org/works/10.1016/0304-3959(91)90005-I

19 November 2022

Kinetics of morphine in patients with renal failure

20

1 reference

10.1016/0304-3959(91)90005-I

https://api.crossref.org/works/10.1016/0304-3959(91)90005-I

19 November 2022

Morphine metabolism in cancer patients on increasing oral doses--no evidence for autoinduction or dose-dependence

21

1 reference

10.1016/0304-3959(91)90005-I

https://api.crossref.org/works/10.1016/0304-3959(91)90005-I

19 November 2022

Kinetics of morphine in patients with renal failure

22

1 reference

10.1016/0304-3959(91)90005-I

https://api.crossref.org/works/10.1016/0304-3959(91)90005-I

19 November 2022

Studies on morphine disposition: influence of renal failure on the kinetics of morphine and its metabolites

23

1 reference

10.1016/0304-3959(91)90005-I

https://api.crossref.org/works/10.1016/0304-3959(91)90005-I

19 November 2022

Analgesic Effect of Morphine Glucuronides

24

1 reference

10.1016/0304-3959(91)90005-I

https://api.crossref.org/works/10.1016/0304-3959(91)90005-I

19 November 2022

Determination of morphine, morphine-3-glucuronide and (tentatively) morphine-6-glucuronide in plasma and urine using ion-pair high-performance liquid chromatography

26

1 reference

10.1016/0304-3959(91)90005-I

https://api.crossref.org/works/10.1016/0304-3959(91)90005-I

19 November 2022

Influence of renal function on the elimination of morphine and morphine glucuronides.

27

1 reference

10.1016/0304-3959(91)90005-I

https://api.crossref.org/works/10.1016/0304-3959(91)90005-I

19 November 2022

Renal failure does not impair the metabolism of morphine

28

1 reference

10.1016/0304-3959(91)90005-I

https://api.crossref.org/works/10.1016/0304-3959(91)90005-I

19 November 2022

Identifiers

10.1016/0304-3959(91)90005-I

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1771088%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1771088%20AND%20SRC:MED&resulttype=core&format=json

18 September 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q67823700&oldid=1775115562"